KNTE

Kinnate Biopharma Inc. Common Stock

Delisted

KNTE was delisted on the 2nd of April, 2024.

73 hedge funds and large institutions have $493M invested in Kinnate Biopharma Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 13 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
73
Holders Change
-3
Holders Change %
-3.95%
% of All Funds
1.23%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.1%
New
14
Increased
27
Reduced
13
Closed
15
Calls
$615K
Puts
Net Calls
+$615K
Net Calls Change
+$97K
Name Holding Trade Value Shares
Change
Shares
Change %
State of Wisconsin Investment Board
76
State of Wisconsin Investment Board
Wisconsin
-$197K -17,500 Closed
Squarepoint
77
Squarepoint
New York
-$158K -14,064 Closed
Millennium Management
78
Millennium Management
New York
-$154K -13,683 Closed
UBS AM
79
UBS AM
Illinois
-$137K -12,130 Closed
VEA
80
Virtus ETF Advisers
New York
-$103K -9,184 Closed
Ensign Peak Advisors
81
Ensign Peak Advisors
Utah
-$59K -5,263 Closed
QT
82
Quantbot Technologies
New York
-$27K -2,400 Closed
IC
83
Ikarian Capital
Texas
-$22K -1,990 Closed
PNC Financial Services Group
84
PNC Financial Services Group
Pennsylvania
-$2K -178 Closed
CAPTRUST Financial Advisors
85
CAPTRUST Financial Advisors
North Carolina
-$1K -46 Closed